Lipocine (LPCN) Stock: Buy, Sell, or Hold?
$1.62
+0.03 (+1.89%)
â˛
5d:
+5.88%
30d:
-4.14%
90d:
-23.22%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (50%)
Quality Score
32/100
Position
FAIR
30-Day Fair Range
$1.43 â $1.83
Position: FAIR
Forward P/E & Valuation
-1.3x
Next 12M consensus est.
Wall Street Target
$5.00
+208.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.36 / $1.74
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: LPCN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When LPCN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: LPCN is currently trading at $1.62, which is considered fair relative to its 30-day fair value range of $1.43 to $1.83.
Technical Outlook: Technically, LPCN is in a strong downtrend. Immediate support is located at $1.36, while resistance sits at $1.74.
Market Sentiment: LPCN scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.00 (+208.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LPCN is in a strong downtrend. Immediate support is located at $1.36, while resistance sits at $1.74.
Market Sentiment: LPCN scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.00 (+208.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.43 -
$1.83
Company Quality Score
32/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
50.0%
Trading Range & Key Levels
30-Day Trading Range
$1.43 -
$1.83
Current vs Trading Range
FAIR
Support Level
$1.36
Resistance Level
$1.74
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 208.6% below Wall St target ($5.00)
- WARNING: Composite score 32/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.33
Wall Street Target
$5.00
(+208.6%)
Revenue Growth (YoY)
-69.5%
Share LPCN Analysis
Share this live LPCN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LPCN)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 6, 2026
Daily AI digest
AI Retail Discussion Summary:
Lipocine reported a loss in Q3 2026 with revenue of $2.3 million. No significant news or price level mentions in the StockTwits message.
Key Retail Themes:
earnings report
market performance
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:02 AM ET
Data refreshes hourly during market hours. Next update: 6:02 AM
Data refreshes hourly during market hours. Next update: 6:02 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LPCN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 52 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 50 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 37 SELL |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
21 analysts |
$650 | 32 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LPCN Research Pages
